Good day, ladies and gentlemen, and welcome to Hikma Pharmaceuticals April 2026 Trading update. [Operator Instructions]. I will now hand over to the Hikma IR team. Please go ahead. Good morning, ...
Good morning, and welcome to the SGS Q1 2026 Sales Update. I'm here with Geraldine Picaud, our CEO; and Marta Vlatchkova, our CFO. Please note that this call is being recorded and will be available ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results